Πλοήγηση ανά Συγγραφέα "Triantos, C."
-
Efficacy of Interferon A-2b Monotherapy in B-Thalassemics with Chronic Hepatitis C
Kalafateli, M.; Kourakli, A.; Gatselis, N.; Lambropoulou, P.; Thomopoulos, K.; Tsamandas, A.; Christofidou, M.; Zachou, K.; Jelastopoulou, E.; Nikolopoulou, V.; Symeonidis, A.; Dalekos, G. N.; Lambropoulou-Karatza, C.; Triantos, C. (2015)Background & Aims: Monotherapy with standard or pegylated interferon (PegIFN) remains the first-line treatment for HCV infection in patients with thalassemia major (beta TM), although its long-term impact is still unknown. ... -
HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS
Goulis, I.; Akriviadis, E.; Karatapanis, S.; Deutsch, M.; Dalekos, G.; Raptopoulou-Gigi, M.; Mimidis, K.; Germanidis, G.; Triantos, C.; Drakoulis, C.; Chounta, A.; Tsoplou, F.; Zintzaras, E.; Bakalos, G.; Papatheodoridis, G. (2012) -
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
Goulis, I.; Karatapanis, S.; Akriviadis, E.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M.; Mimidis, K.; Germanidis, G.; Drakoulis, C.; Triantos, C.; Zintzaras, E.; Bakalos, G.; Papatheodoridis, G. (2015)Background & AimsWe assessed predictors of response in HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2a in routine clinical practice. MethodsNinety-five HBeAg-negative patients received ...